Rogers Sugar (RSI) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
27 Apr, 2026Executive summary
Business delivered strong Q2 2025 results, with record consolidated revenues of $326M, driven by robust Maple segment performance and steady Sugar segment demand, including some advance purchasing due to US tariff uncertainty.
Adjusted EBITDA for Q2 2025 was $34.7M, with Maple segment offsetting a Sugar segment decline; Maple achieved record profitability and accounted for over 20% of adjusted EBITDA.
Limited impact from incremental US tariffs on export sales for refined sugar and maple products, but ongoing monitoring of trade situation and potential risks.
Issued new debentures and maintained a strong capital structure to support expansion and future growth.
Financial highlights
Consolidated revenues increased 8% to $326M; Maple segment contributed over 20% of both revenue and adjusted EBITDA.
Adjusted EBITDA for Q2 2025 was $34.7M, down $3.4M year-over-year, but remains historically high; adjusted net earnings per share were $0.13.
Trailing twelve months free cash flow increased nearly 50% to $83M.
Sugar segment revenue up 7% to $261M, with export volumes increasing by 19,000 tons; Maple segment sales volume up 13% year-over-year, with adjusted EBITDA at $7.1M.
Dividend maintained at $0.09 per share.
Outlook and guidance
2025 sugar sales volume outlook set at 785,000 metric tons, a 1% year-over-year increase after adjusting for prior labor disruption.
Guidance reduced by 15,000 metric tons due to softer industrial demand and smaller beet crop.
Maple segment expected to grow by 3 million pounds or 6.5% in 2025, with above-average crop and strong order book.
CapEx (excluding LEAP/LEEP) expected at $25–30M; LEAP/LEEP project spend at $79–80M for 2025.
EBITDA growth expected to be modest but positive for 2025, subject to potential adverse impact of additional US tariffs.
Latest events from Rogers Sugar
- Strong Sugar margins drove Q2 2026 profit growth; LEAP Project and free cash flow remain robust.RSI
Q2 202611 May 2026 - Record 2024 results, LEAP expansion, and all motions passed amid US tariff risks.RSI
AGM 202527 Apr 2026 - Record Q3 adjusted EBITDA and revenue growth, with strong segment margins and robust outlook.RSI
Q3 202427 Apr 2026 - Adjusted EBITDA up 28%, strong segment growth, LEAP costs rise, stable 2025 outlook.RSI
Q4 202427 Apr 2026 - Q1 2025 saw record revenue and EBITDA growth, with LEAP project advancing and tariff risks present.RSI
Q1 202527 Apr 2026 - Record Q3 with revenue and EBITDA growth, strong demand, and LEAP project on track.RSI
Q3 202527 Apr 2026 - Record 2025 profit growth, LEAP Project progress, and higher free cash flow amid tariff risks.RSI
Q4 202527 Apr 2026 - Q1 2026 saw higher earnings and margins, strong free cash flow, and LEAP Project progress.RSI
Q1 202612 Apr 2026 - Record financial results, all motions passed, and LEAP Project advances for future growth.RSI
AGM 202620 Mar 2026